This publication presents readers with a highly effective, affordable, applicable, non-invasive, and quick method to detect exposure to the most dangerous chemical carcinogens, causing a range of life-threatening conditions, including cardiovascular, endocrine, neurological, hematological, dermatological, and malignant diseases. Every year, nearly 20 million people worldwide are diagnosed with cancer, and almost 10 million die from the disease. Many harmful chemical exposures remain unknown and while it is not possible to eliminate carcinogens completely, improving detection and monitoring--particularly through specialized urine analysis--can help define preventive measures that lower carcinogen levels in the body. This is a key focus of preventive oncology, environmental science, and technological innovation. Regrettably, the chemical carcinogens discussed in this book have been used for decades, and in some cases, centuries, without proper evaluation of their effects on human health--a mistake that has cost millions of lives. It is critical to consider the long-term health impacts of products currently in use. Most of the carcinogens presented in this volume have cumulative effects, which makes early detection crucial. By accurately identifying urinary markers of exposure to these carcinogens, it is possible to detect, eliminate, or reduce their sources.

This strategy has the potential to make significant advances in preventive oncology within a relatively short period. This book primarily addresses chemical carcinogens classified as Group 1 by the International Agency for Research on Cancer (IARC). The methods described are highly effective, encompassing the most important carcinogens with high sensitivity in detection. They are also affordable, utilizing existing chemical and medical infrastructure, applicable in any location with HPLC (High-Performance Liquid Chromatography) and ICP (Inductively Coupled Plasma) devices, non-invasive (requiring only urine samples), quick (taking only minutes), and inexpensive (costing just a few dozen euros). The volume aims to contribute to the development, improvement, and implementation of screening methods, particularly for malignant diseases. It supports medical professionals in interpreting the results of HPLC and ICP urinary analyses and asking the right questions to provide guidance on reducing or avoiding exposure to dangerous carcinogens. In some cases, doctors may also identify the sources of carcinogen exposure and inform authorities to address and eliminate these hazards.